KAIPHARM

KaiPharm is an innovative pharmaceutical company based on Big Data, Bioinformatics, and A.I. Technology... KaiPharm developed unique virtual screening methods by mining drug screening big data, and generated NGS-based full transcriptome data (KMAP) for thousands of drugs/compounds. We operate commercial service for drug-induced transcriptome (KMAP Express). A number of collaborative projects & services are performed with pharmaceutical companies, venture companies and research organizations regarding hit generation, drug's MoA, indication discovery, drug repositioning, side effects, and disease subtype markers... We Provide a roadmap to understand the overall drug characteristics and mechanism of action, such as drug target prediction, candidate substance prediction, drug repositioning, new indication discovery, and side-effect prediction.

Also known as: Kaipharm Co., KaiPharm Co., Ltd.

Primary location: Seoul South Korea